Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for ADPKD
NCT00346918Phase 3Completed
- Sponsor
- University of Zurich
- Start
- Jun 2006
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in autosomal dominant polycystic kidney disease (ADPKD), sponsored by University of Zurich. Started Jun 2006; status: completed.
02
Drugs
sirolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT00346918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346918.